Skip to main content
. 2020 Mar 29;12(4):821. doi: 10.3390/cancers12040821

Figure 1.

Figure 1

Companion and theranostic approaches in nuclear medicine. Phenotypic imaging (left) achieved using a PET- or SPECT-dedicated radiolabel compound can be followed by a non-radioactive therapy (right, top) or a radioactive therapy (right, bottom).